About TorMagnus Pharmaceuticals
At TorMagnus, we’re leveraging genetics and computation to identify new treatments for disease, starting with Parkinson's disease.
Financials Beta
Business Model: Not Specified
Revenues: Not Specified
Expenses: Not Specified
Debt: Request
Operating Status: Active
Funding Raised: $0
Investment Rounds: 0 Rounds
Funding Stage: Not Specified
Last Funding Date: Not Specified